362
Views
40
CrossRef citations to date
0
Altmetric
Review

An update on pharmacological approaches to neurodegenerative diseases

, , , , &
Pages 59-72 | Published online: 07 Dec 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Khalid A. Agha, Nader E. Abo-Dya, Abdul Rashid Issahaku, Clement Agoni, Mahmoud E. S. Soliman, Eatedal H. Abdel-Aal, Zakaria K. Abdel-Samii & Tarek S. Ibrahim. (2022) Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1241-1256.
Read now
Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt & Péter Mátyus. (2012) Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 21:9, pages 1267-1308.
Read now
Maria Novella Romanelli & Fulvio Gualtieri. (2007) The quest for the treatment of cognitive impairment: α7 nicotinic and α5 GABAA receptor modulators. Expert Opinion on Therapeutic Patents 17:11, pages 1365-1377.
Read now
Boben Benjamin & Alistair Burns. (2007) Donepezil for Alzheimer’s disease. Expert Review of Neurotherapeutics 7:10, pages 1243-1249.
Read now

Articles from other publishers (36)

Matheus de Freitas Silva, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Cindy Juliet Cristancho Ortiz, Graziella dos Reis Rosa Franco, Januário Tomás Ernesto, Caio Miranda Damásio, Gabriel Pinto da Silva Fonseca, Isabela Marie Fernandes Silva, Larissa Emika Massuda, Maria Fernanda da Silva, Thâmara Gaspar Campos Thâmara Gaspar Campos, Priscila da Mota Braga & Claudio Viegas. 2023. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 1 157 .
Sarah Macedo Vaz, Matheus de Freitas Silva, Graziella dos Reis Rosa Franco, Marcos Jorge R. Guimarães, Fernanda Motta R. da Silva, Newton Gonçalves Castro, Isabella Alvim Guedes, Laurent E. Dardenne, Marina Amaral Alves, Rafael Garrett da Costa, Gabriela Beserra Pinheiro, Letícia Germino Veras, Márcia Renata Mortari, Letizia Pruccoli, Andrea Tarozzi & Cláudio ViegasJr.Jr.. (2022) Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer’s disease. Bioorganic & Medicinal Chemistry 71, pages 116952.
Crossref
Nira Ben-Jonathan, Dana C. Borcherding & Eric R. Hugo. (2022) Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications. Critical Reviews™ in Oncogenesis 27:2, pages 51-71.
Crossref
Fernanda Rodríguez-Enríquez, María Carmen Costas-Lago, Pedro Besada, Miguel Alonso-Pena, Iria Torres-Terán, Dolores Viña, José Ángel Fontenla, Mattia Sturlese, Stefano Moro, Elias Quezada & Carmen Terán. (2020) Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy. Bioorganic Chemistry 104, pages 104203.
Crossref
Sergei G. Gaidin, Valery P. Zinchenko, Alexander I. Sergeev, Ilia Y. Teplov, Valentina N. Mal'tseva & Artem M. Kosenkov. (2020) Activation of alpha‐2 adrenergic receptors stimulates GABA release by astrocytes. Glia 68:6, pages 1114-1130.
Crossref
Lorane I. da S. Hage-Melim, Jaderson V. Ferreira, Nayana K.S. de Oliveira, Lenir C. Correia, Marcos R.S. Almeida, João G.C. Poiani, Carlton A. Taft & Carlos H.T. de Paula da Silva. (2019) The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases. Current Organic Chemistry 23:3, pages 335-360.
Crossref
Kurt Farrell, Jyotsna Joshi & Chandrasekhar R. Kothapalli. (2017) Injectable uncrosslinked biomimetic hydrogels as candidate scaffolds for neural stem cell delivery. Journal of Biomedical Materials Research Part A 105:3, pages 790-805.
Crossref
Chi Huu Nguyen, Christopher Krewenka, Khaled Radad, Barbara Kranner, Alexandra Huber, Johanna Catharina Duvigneau, Ingrid Miller & Rudolf Moldzio. (2016) THC (?9-Tetrahydrocannabinol) Exerts Neuroprotective Effect in Glutamate-affected Murine Primary Mesencephalic Cultures Through Restoring Mitochondrial Membrane Potential and Anti-apoptosis Involving CB 1 Receptor-dependent Mechanism . Phytotherapy Research 30:12, pages 2044-2052.
Crossref
Inga Antyborzec, Valerie B. O’Leary, James O. Dolly & Saak V. Ovsepian. (2016) Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain. Neurotherapeutics 13:4, pages 859-870.
Crossref
Tian He, Liang Qi, Jing Zhang, Ya-Li Huang & Zhi-Qi Zhang. (2015) Enhanced graphene quantum dot fluorescence nanosensor for highly sensitive acetylcholinesterase assay and inhibitor screening. Sensors and Actuators B: Chemical 215, pages 24-29.
Crossref
Lorena Almagro, Francisco Fernández-Pérez & Maria Pedreño. (2015) Indole Alkaloids from Catharanthus roseus: Bioproduction and Their Effect on Human Health. Molecules 20:2, pages 2973-3000.
Crossref
Dan Luo, Terry C. T. Or, Cindy L. H. Yang & Allan S. Y. Lau. (2014) Anti-Inflammatory Activity of Iridoid and Catechol Derivatives from Eucommia ulmoides Oliver . ACS Chemical Neuroscience 5:9, pages 855-866.
Crossref
V. Manigandan, S. Gurudeeban, K. Satyavani & T. Ramanathan. (2014) Molecular Docking Studies of Rhizophora mucronata Alkaloids Against Neuroinflammatory Marker Cyclooxygenase 2. International Journal of Biological Chemistry 8:2, pages 91-99.
Crossref
Shigeki Moriguchi, Tomoya Tanaka, Toshio Narahashi & Kohji Fukunaga. (2013) Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N -methyl- D -aspartate receptor . Hippocampus 23:10, pages 942-951.
Crossref
Shigeki Moriguchi, Tomoya Tanaka, Hideaki Tagashira, Toshio Narahashi & Kohji Fukunaga. (2013) Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice. Behavioural Brain Research 242, pages 150-157.
Crossref
Meera Shanmuganathan & Philip Britz-McKibbin. (2013) High quality drug screening by capillary electrophoresis: A review. Analytica Chimica Acta 773, pages 24-36.
Crossref
Stanley C. C. Chik, Terry C. T. Or, D. Luo, Cindy L. H. Yang & Allan S. Y. Lau. (2013) Pharmacological Effects of Active Compounds on Neurodegenerative Disease with Gastrodia and Uncaria Decoction, a Commonly Used Poststroke Decoction. The Scientific World Journal 2013, pages 1-22.
Crossref
Maria Laura Bolognesi, Carlo Melchiorre, Cornelis J. Van der Schyf & Moussa Youdim. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs 290 315 .
Yaodong Zhang, Tingting Hei, Yanan Cai, Qunqun Gao & Qi Zhang. (2012) Affinity Binding-Guided Fluorescent Nanobiosensor for Acetylcholinesterase Inhibitors via Distance Modulation between the Fluorophore and Metallic Nanoparticle. Analytical Chemistry 84:6, pages 2830-2836.
Crossref
Johanna Graßmann, Romy K. Scheerle & Thomas Letzel. (2011) Functional proteomics: application of mass spectrometry to the study of enzymology in complex mixtures. Analytical and Bioanalytical Chemistry 402:2, pages 625-645.
Crossref
Jennifer D. Lanning & Stephen C. Meredith. 2012. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases 433 560 .
Elisabetta Martini, Lorenzo Di Cesare Mannelli, Gianluca Bartolucci, Carlo Bertucci, Silvia Dei, Carla Ghelardini, Luca Guandalini, Dina Manetti, Serena Scapecchi, Elisabetta Teodori & Maria Novella Romanelli. (2011) Synthesis and Biological Evaluation of 3,7-Diazabicyclo[4.3.0]nonan-8-ones as Potential Nootropic and Analgesic Drugs. Journal of Medicinal Chemistry 54:7, pages 2512-2516.
Crossref
P. Matthew Joyner & Robert H. Cichewicz. (2011) Bringing natural products into the fold – exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases. Nat. Prod. Rep. 28:1, pages 26-47.
Crossref
Ha-Na Woo, Sang-Ha Baik, Jong-Sung Park, A-Ryeong Gwon, Sunghee Yang, Young-Kwang Yun & Dong-Gyu Jo. (2011) Secretases as therapeutic targets for Alzheimer’s disease. Biochemical and Biophysical Research Communications 404:1, pages 10-15.
Crossref
Elisabetta Martini, Alberto Salvicchi, Carla Ghelardini, Dina Manetti, Silvia Dei, Luca Guandalini, Cecilia Martelli, Michele Melchiorre, Cristina Cellai, Serena Scapecchi, Elisabetta Teodori & Maria Novella Romanelli. (2009) Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. Bioorganic & Medicinal Chemistry 17:21, pages 7606-7614.
Crossref
Eva Kontsekova, Natalia Ivanovova, Martina Handzusova & Michal Novak. (2009) Chaperone-Like Antibodies in Neurodegenerative Tauopathies: Implication for Immunotherapy. Cellular and Molecular Neurobiology 29:6-7, pages 793-798.
Crossref
Patrizia Bottoni, Bruno Giardina & Roberto Scatena. (2009) Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications. PROTEOMICS - Clinical Applications 3:6, pages 636-653.
Crossref
Trevor W. Stone, Stefania Ceruti & Mariapia P. Abbracchio. 2009. Adenosine Receptors in Health and Disease. Adenosine Receptors in Health and Disease 535 587 .
Elisabetta Martini, Monica Norcini, Carla Ghelardini, Dina Manetti, Silvia Dei, Luca Guandalini, Michele Melchiorre, Simona Pagella, Serena Scapecchi, Elisabetta Teodori & Maria Novella Romanelli. (2008) Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. Bioorganic & Medicinal Chemistry 16:23, pages 10034-10042.
Crossref
Gennady A. Buznikov, Lyudmila A. Nikitina, Frederic J. Seidler, Theodore A. Slotkin, Vladimir V. Bezuglov, Ivan Milošević, Lidija Lazarević, Ljubica Rogač, Sabera Ruzdijić & Ljubiša M. Rakić. (2008) Amyloid precursor protein 96–110 and β-amyloid 1–42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids. Neurotoxicology and Teratology 30:6, pages 503-509.
Crossref
Yuanbin Liu, Richard Dargusch, Pamela Maher & David Schubert. (2008) A broadly neuroprotective derivative of curcumin. Journal of Neurochemistry 105:4, pages 1336-1345.
Crossref
Gennady A. Buznikov, Lyudmila A. Nikitina, Vladimir V. Bezuglov, Ivan Milošević, Lidija Lazarević, Ljubica Rogač, Sabera Ruzdijić, Theodore A. Slotkin & Ljubiša M. Rakić. (2008) Sea urchin embryonic development provides a model for evaluating therapies against β-amyloid toxicity. Brain Research Bulletin 75:1, pages 94-100.
Crossref
Alice W. Flaherty. 2008. Massachusetts General Hospital Comprehensive Clinical Psychiatry. Massachusetts General Hospital Comprehensive Clinical Psychiatry 1091 1105 .
David J Burn. (2007) Clinical assessment of progressive supranuclear palsy over time: new rating scale validated. Nature Clinical Practice Neurology 3:11, pages 600-601.
Crossref
Davide Cervia & Paola Bagnoli. (2007) An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacology & Therapeutics 116:2, pages 322-341.
Crossref
Ruth Luthi-Carter. (2007) Huntington's and other polyglutamine diseases: many effects of single gene mutations. Drug Discovery Today: Disease Mechanisms 4:2, pages 111-119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.